HUP0104622A2 - Fokozott hatású emberi influenzaoltóanyag-készítmény és eljárás annak előállítására - Google Patents

Fokozott hatású emberi influenzaoltóanyag-készítmény és eljárás annak előállítására

Info

Publication number
HUP0104622A2
HUP0104622A2 HU0104622A HUP0104622A HUP0104622A2 HU P0104622 A2 HUP0104622 A2 HU P0104622A2 HU 0104622 A HU0104622 A HU 0104622A HU P0104622 A HUP0104622 A HU P0104622A HU P0104622 A2 HUP0104622 A2 HU P0104622A2
Authority
HU
Hungary
Prior art keywords
preparation
influenza vaccine
human influenza
vaccine composition
increased activity
Prior art date
Application number
HU0104622A
Other languages
English (en)
Inventor
Lóránd Bertók
István Jankovics
Original Assignee
Lóránd Bertók
István Jankovics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lóránd Bertók, István Jankovics filed Critical Lóránd Bertók
Priority to HU0104622A priority Critical patent/HUP0104622A3/hu
Publication of HU0104622D0 publication Critical patent/HU0104622D0/hu
Publication of HUP0104622A2 publication Critical patent/HUP0104622A2/hu
Publication of HUP0104622A3 publication Critical patent/HUP0104622A3/hu

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A találmány tárgya fokozott hatású emberi influenza oltóanyag-készítmény, amely önmagában ismert tartósított és inaktívált,dózisonként legalább 15 mg hemagglutinint (a továbbiakban, röviden HA-t) tartalmazó influenza vírusszuszpenziót, 0,1-1,3 mg/ml alumínium-hidroxidot vagy alumínium-foszfátot és 0,1-1,0 mg sugárdetoxikáltbakteriális endotoxin-készítményt tartalmaz. A találmány a fentikészítmény előállítására is vonatkozik. Ó
HU0104622A 2001-10-31 2001-10-31 Human influenza vaccine composition with increased activity and process for the preparation thereof HUP0104622A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU0104622A HUP0104622A3 (en) 2001-10-31 2001-10-31 Human influenza vaccine composition with increased activity and process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0104622A HUP0104622A3 (en) 2001-10-31 2001-10-31 Human influenza vaccine composition with increased activity and process for the preparation thereof

Publications (3)

Publication Number Publication Date
HU0104622D0 HU0104622D0 (en) 2002-01-28
HUP0104622A2 true HUP0104622A2 (hu) 2003-07-28
HUP0104622A3 HUP0104622A3 (en) 2003-08-28

Family

ID=89979859

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104622A HUP0104622A3 (en) 2001-10-31 2001-10-31 Human influenza vaccine composition with increased activity and process for the preparation thereof

Country Status (1)

Country Link
HU (1) HUP0104622A3 (hu)

Also Published As

Publication number Publication date
HU0104622D0 (en) 2002-01-28
HUP0104622A3 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
EP1820853A3 (en) Recombinant influenza viruses for vaccines and gene therapy
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
NO20001768L (no) Viruskapsomervaksine, fremgangsmÕte til fremstilling samt anvendelse derav
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
EP0915648A4 (hu)
ATE270707T1 (de) Entepneumovirus und entsprechendes impfstoff
PT1741443E (pt) Combinação de vacinas para a meningite b/c
MY125356A (en) Moxifloxacin/sodium chloride formulation
EP2275121A3 (en) Protein-based streptococcus pneumoniae vaccines
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
MY144492A (en) Human papillomavirus vaccine comprising hpv 16 and hpv 18 virus like particles, which induce cross protection against other hpv types
CA2294921A1 (en) Levobupivacaine and its use
MXPA02012249A (es) Peptidos, composiciones y metodos para el tratamiento de burkholderia cepacia.
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
WO2004091524A3 (en) Respiratory virus vaccines
WO2001055111A8 (en) Biaryl compounds, their preparation and their use in therapy
CO5280138A1 (es) Virus atenuados e inocuos de la diarrea virica bovina para en vacas gestantes
WO2003009859A1 (fr) Immunotherapie pour humains
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
WO2002053149A3 (de) Arzneimittel enthaltend ein polyamin als wirksubstanz
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
AP9400647A0 (en) Medicaments for use in treatment of HIV or cancer patients.
HUP0104622A2 (hu) Fokozott hatású emberi influenzaoltóanyag-készítmény és eljárás annak előállítására
ITTO20020284A0 (it) Procedimento per la sterilizzazione e la neutralizzazione di odori dell'aria.
PT1406859E (pt) Derivados substituídos de 4-aminociclo-hexanol